The global Molecular Influenza Test market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rapid molecular assays are a kind of molecular influenza diagnostic test to detect influenza virus nucleic acids in upper respiratory tract specimens with high sensitivity (90-95%) and specificity. FDA-cleared rapid molecular assays are available that produce results in approximately 15-30 minutes. Some of these rapid molecular assays are CLIA-waived for point-of-care use.
This report aims to provide a comprehensive presentation of the global market for Molecular Influenza Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Influenza Test. This report contains market size and forecasts of Molecular Influenza Test in global, including the following market information:
Global Molecular Influenza Test Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
RT-PCR Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Molecular Influenza Test include F. Hoffmann-La Roche, Quidel Corporation, Thermo Fisher Scientific, Abbott Laboratories, Becton, Dickinson, and Company, DiaSorin and bioMrieux, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Molecular Influenza Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Influenza Test Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Molecular Influenza Test Market Segment Percentages, by Type, 2022 (%)
- RT-PCR
- TMA
- LAMP
- NASBA
- Other
Global Molecular Influenza Test Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Molecular Influenza Test Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Clinical Laboratories
- Other End-User
Global Molecular Influenza Test Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Molecular Influenza Test Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Molecular Influenza Test revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Molecular Influenza Test revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- F. Hoffmann-La Roche
- Quidel Corporation
- Thermo Fisher Scientific
- Abbott Laboratories
- Becton, Dickinson, and Company
- DiaSorin
- bioMrieux
Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Influenza Test, market overview.
Chapter 2: Global Molecular Influenza Test market size in revenue.
Chapter 3: Detailed analysis of Molecular Influenza Test company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Influenza Test in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Molecular Influenza Test Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Influenza Test Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Influenza Test Overall Market Size
2.1 Global Molecular Influenza Test Market Size: 2022 VS 2030
2.2 Global Molecular Influenza Test Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Influenza Test Players in Global Market
3.2 Top Global Molecular Influenza Test Companies Ranked by Revenue
3.3 Global Molecular Influenza Test Revenue by Companies
3.4 Top 3 and Top 5 Molecular Influenza Test Companies in Global Market, by Revenue in 2022
3.5 Global Companies Molecular Influenza Test Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Influenza Test Players in Global Market
3.6.1 List of Global Tier 1 Molecular Influenza Test Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Influenza Test Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Molecular Influenza Test Market Size Markets, 2022 & 2030
4.1.2 RT-PCR
4.1.3 TMA
4.1.4 LAMP
4.1.5 NASBA
4.1.6 Other
4.2 By Type - Global Molecular Influenza Test Revenue & Forecasts
4.2.1 By Type - Global Molecular Influenza Test Revenue, 2018-2023
4.2.2 By Type - Global Molecular Influenza Test Revenue, 2024-2030
4.2.3 By Type - Global Molecular Influenza Test Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Influenza Test Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinical Laboratories
5.1.4 Other End-User
5.2 By Application - Global Molecular Influenza Test Revenue & Forecasts
5.2.1 By Application - Global Molecular Influenza Test Revenue, 2018-2023
5.2.2 By Application - Global Molecular Influenza Test Revenue, 2024-2030
5.2.3 By Application - Global Molecular Influenza Test Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Molecular Influenza Test Market Size, 2022 & 2030
6.2 By Region - Global Molecular Influenza Test Revenue & Forecasts
6.2.1 By Region - Global Molecular Influenza Test Revenue, 2018-2023
6.2.2 By Region - Global Molecular Influenza Test Revenue, 2024-2030
6.2.3 By Region - Global Molecular Influenza Test Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Molecular Influenza Test Revenue, 2018-2030
6.3.2 US Molecular Influenza Test Market Size, 2018-2030
6.3.3 Canada Molecular Influenza Test Market Size, 2018-2030
6.3.4 Mexico Molecular Influenza Test Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Molecular Influenza Test Revenue, 2018-2030
6.4.2 Germany Molecular Influenza Test Market Size, 2018-2030
6.4.3 France Molecular Influenza Test Market Size, 2018-2030
6.4.4 U.K. Molecular Influenza Test Market Size, 2018-2030
6.4.5 Italy Molecular Influenza Test Market Size, 2018-2030
6.4.6 Russia Molecular Influenza Test Market Size, 2018-2030
6.4.7 Nordic Countries Molecular Influenza Test Market Size, 2018-2030
6.4.8 Benelux Molecular Influenza Test Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Molecular Influenza Test Revenue, 2018-2030
6.5.2 China Molecular Influenza Test Market Size, 2018-2030
6.5.3 Japan Molecular Influenza Test Market Size, 2018-2030
6.5.4 South Korea Molecular Influenza Test Market Size, 2018-2030
6.5.5 Southeast Asia Molecular Influenza Test Market Size, 2018-2030
6.5.6 India Molecular Influenza Test Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Molecular Influenza Test Revenue, 2018-2030
6.6.2 Brazil Molecular Influenza Test Market Size, 2018-2030
6.6.3 Argentina Molecular Influenza Test Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Influenza Test Revenue, 2018-2030
6.7.2 Turkey Molecular Influenza Test Market Size, 2018-2030
6.7.3 Israel Molecular Influenza Test Market Size, 2018-2030
6.7.4 Saudi Arabia Molecular Influenza Test Market Size, 2018-2030
6.7.5 UAE Molecular Influenza Test Market Size, 2018-2030
7 Molecular Influenza Test Companies Profiles
7.1 F. Hoffmann-La Roche
7.1.1 F. Hoffmann-La Roche Company Summary
7.1.2 F. Hoffmann-La Roche Business Overview
7.1.3 F. Hoffmann-La Roche Molecular Influenza Test Major Product Offerings
7.1.4 F. Hoffmann-La Roche Molecular Influenza Test Revenue in Global Market (2018-2023)
7.1.5 F. Hoffmann-La Roche Key News & Latest Developments
7.2 Quidel Corporation
7.2.1 Quidel Corporation Company Summary
7.2.2 Quidel Corporation Business Overview
7.2.3 Quidel Corporation Molecular Influenza Test Major Product Offerings
7.2.4 Quidel Corporation Molecular Influenza Test Revenue in Global Market (2018-2023)
7.2.5 Quidel Corporation Key News & Latest Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Summary
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Molecular Influenza Test Major Product Offerings
7.3.4 Thermo Fisher Scientific Molecular Influenza Test Revenue in Global Market (2018-2023)
7.3.5 Thermo Fisher Scientific Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Molecular Influenza Test Major Product Offerings
7.4.4 Abbott Laboratories Molecular Influenza Test Revenue in Global Market (2018-2023)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 Becton, Dickinson, and Company
7.5.1 Becton, Dickinson, and Company Company Summary
7.5.2 Becton, Dickinson, and Company Business Overview
7.5.3 Becton, Dickinson, and Company Molecular Influenza Test Major Product Offerings
7.5.4 Becton, Dickinson, and Company Molecular Influenza Test Revenue in Global Market (2018-2023)
7.5.5 Becton, Dickinson, and Company Key News & Latest Developments
7.6 DiaSorin
7.6.1 DiaSorin Company Summary
7.6.2 DiaSorin Business Overview
7.6.3 DiaSorin Molecular Influenza Test Major Product Offerings
7.6.4 DiaSorin Molecular Influenza Test Revenue in Global Market (2018-2023)
7.6.5 DiaSorin Key News & Latest Developments
7.7 bioM?rieux
7.7.1 bioM?rieux Company Summary
7.7.2 bioM?rieux Business Overview
7.7.3 bioM?rieux Molecular Influenza Test Major Product Offerings
7.7.4 bioM?rieux Molecular Influenza Test Revenue in Global Market (2018-2023)
7.7.5 bioM?rieux Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Molecular Influenza Test Market Opportunities & Trends in Global Market
Table 2. Molecular Influenza Test Market Drivers in Global Market
Table 3. Molecular Influenza Test Market Restraints in Global Market
Table 4. Key Players of Molecular Influenza Test in Global Market
Table 5. Top Molecular Influenza Test Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Molecular Influenza Test Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Molecular Influenza Test Revenue Share by Companies, 2018-2023
Table 8. Global Companies Molecular Influenza Test Product Type
Table 9. List of Global Tier 1 Molecular Influenza Test Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Influenza Test Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Molecular Influenza Test Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Molecular Influenza Test Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Molecular Influenza Test Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Molecular Influenza Test Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Molecular Influenza Test Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Molecular Influenza Test Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Molecular Influenza Test Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Molecular Influenza Test Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Molecular Influenza Test Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Molecular Influenza Test Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Molecular Influenza Test Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Molecular Influenza Test Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Molecular Influenza Test Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Molecular Influenza Test Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Molecular Influenza Test Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Molecular Influenza Test Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Molecular Influenza Test Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Molecular Influenza Test Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Molecular Influenza Test Revenue, (US$, Mn), 2024-2030
Table 30. F. Hoffmann-La Roche Company Summary
Table 31. F. Hoffmann-La Roche Molecular Influenza Test Product Offerings
Table 32. F. Hoffmann-La Roche Molecular Influenza Test Revenue (US$, Mn) & (2018-2023)
Table 33. F. Hoffmann-La Roche Key News & Latest Developments
Table 34. Quidel Corporation Company Summary
Table 35. Quidel Corporation Molecular Influenza Test Product Offerings
Table 36. Quidel Corporation Molecular Influenza Test Revenue (US$, Mn) & (2018-2023)
Table 37. Quidel Corporation Key News & Latest Developments
Table 38. Thermo Fisher Scientific Company Summary
Table 39. Thermo Fisher Scientific Molecular Influenza Test Product Offerings
Table 40. Thermo Fisher Scientific Molecular Influenza Test Revenue (US$, Mn) & (2018-2023)
Table 41. Thermo Fisher Scientific Key News & Latest Developments
Table 42. Abbott Laboratories Company Summary
Table 43. Abbott Laboratories Molecular Influenza Test Product Offerings
Table 44. Abbott Laboratories Molecular Influenza Test Revenue (US$, Mn) & (2018-2023)
Table 45. Abbott Laboratories Key News & Latest Developments
Table 46. Becton, Dickinson, and Company Company Summary
Table 47. Becton, Dickinson, and Company Molecular Influenza Test Product Offerings
Table 48. Becton, Dickinson, and Company Molecular Influenza Test Revenue (US$, Mn) & (2018-2023)
Table 49. Becton, Dickinson, and Company Key News & Latest Developments
Table 50. DiaSorin Company Summary
Table 51. DiaSorin Molecular Influenza Test Product Offerings
Table 52. DiaSorin Molecular Influenza Test Revenue (US$, Mn) & (2018-2023)
Table 53. DiaSorin Key News & Latest Developments
Table 54. bioM?rieux Company Summary
Table 55. bioM?rieux Molecular Influenza Test Product Offerings
Table 56. bioM?rieux Molecular Influenza Test Revenue (US$, Mn) & (2018-2023)
Table 57. bioM?rieux Key News & Latest Developments
List of Figures
Figure 1. Molecular Influenza Test Segment by Type in 2022
Figure 2. Molecular Influenza Test Segment by Application in 2022
Figure 3. Global Molecular Influenza Test Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Molecular Influenza Test Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Molecular Influenza Test Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Molecular Influenza Test Revenue in 2022
Figure 8. By Type - Global Molecular Influenza Test Revenue Market Share, 2018-2030
Figure 9. By Application - Global Molecular Influenza Test Revenue Market Share, 2018-2030
Figure 10. By Type - Global Molecular Influenza Test Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Molecular Influenza Test Revenue Market Share, 2018-2030
Figure 12. By Application - Global Molecular Influenza Test Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Molecular Influenza Test Revenue Market Share, 2018-2030
Figure 14. By Region - Global Molecular Influenza Test Revenue Market Share, 2018-2030
Figure 15. By Country - North America Molecular Influenza Test Revenue Market Share, 2018-2030
Figure 16. US Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Molecular Influenza Test Revenue Market Share, 2018-2030
Figure 20. Germany Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 21. France Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Molecular Influenza Test Revenue Market Share, 2018-2030
Figure 28. China Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 32. India Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Molecular Influenza Test Revenue Market Share, 2018-2030
Figure 34. Brazil Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Molecular Influenza Test Revenue Market Share, 2018-2030
Figure 37. Turkey Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Molecular Influenza Test Revenue, (US$, Mn), 2018-2030
Figure 41. F. Hoffmann-La Roche Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Quidel Corporation Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Thermo Fisher Scientific Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Abbott Laboratories Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Becton, Dickinson, and Company Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. DiaSorin Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. bioM?rieux Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
